Abstract
Objective:Functional outcomes were prospectively compared between the standard Roux-en-Y and Double-tract reconstruction following a total gastrectomy and D2 lymphadenectomy.Methods:One hundred ten patients with gastric cancer were divided into two groups by the type of reconstruction. Age, gender, T stage, AJCC stage, length of operation, BMI (body mass index, kg/m2), time to soft diet, postoperative leakage of the esophagojejunostomy (EJS), stricture of the EJS, meal intake, and quality of life (QOL) were recorded.Results:The mean age in the R-Y group was 61.57, with the SD of 9.53, while in the DT group the mean age was 60.17 with a SD of 9.92. The BMI decline in the R-Y group was 4.09 with a SD of 1.11, while in the DT group it was 2.85 with a SD of 1.27. We found a highly significant statistical difference between the two groups in the rate of the BMI decline (p<0,001). We found no statistically significant difference regarding QOL between the two groups, p>0.05.Conclusions:The Double tract reconstruction is a simple procedure and the rate of the BMI decline is much smaller compared to the Roux-en-Y group.
Highlights
Almost one million (951 600) new cases of gastric cancer (GC) were diagnosed globally in 2012, resulting in approximately 723 100 deaths.[1]
The countries with the highest rates for GC remain the east Asian, the south American and east European countries, while the incidence is significantly lower for the population of Northern America and western European countries.[2 140 000] cases and 107 000 deaths occurred in Europe annually.[3]
A total number of 51 patients were reconstructed with the Rouxen-Y anastomosis (R-Y) method, while 59 of them reconstructed with the double tract (DT) method
Summary
Almost one million (951 600) new cases of gastric cancer (GC) were diagnosed globally in 2012, resulting in approximately 723 100 deaths.[1] It is very important to point out the variation in incidence on a global level. The countries with the highest rates for GC remain the east Asian, the south American and east European countries, while the incidence is significantly lower for the population of Northern America and western European countries.[2 140 000] cases and 107 000 deaths occurred in Europe annually.[3] Over the past 50 years a steady decline in GC incidence has been observed, in north America or western Europe, and in the countries with high prevalence for GC. The extent of resection in GC patients is determined by the preoperative stage. Surgical treatment for gastric cancer, especially at an early stage, can be a curative procedure.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.